FREELINE THERAPEUTICS HOLDIN (FRLN)
US35655L2060 - ADR
| TTM (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -49.93M | -88.97M | -140.39M | -96.32M | -53.91M | |||
| Depreciation Amortization | 1.45M | 1.74M | 2.39M | 1.91M | 1.54M | |||
| Income Taxes - Deferred | N/A | -160.00K | -170.00K | -160.00K | N/A | |||
| Change In Working Capital | 2.57M | 8.77M | 19.74M | -6.68M | -1.41M | |||
| Other non cash items | -18.48M | 100.00K | 10.87M | 6.28M | 1.46M | |||
| OPERATING CASH FLOW | -64.54M | -78.52M | -107.56M | -94.97M | -52.32M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -4.54M | -7.01M | -4.27M | -2.51M | -3.02M | |||
| Other Investing Activity | N/A | 0.00 | 0.00 | 130.00K | N/A | |||
| INVESTING CASH FLOW | 19.72M | -7.01M | -4.27M | -2.39M | -3.02M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 112.00K | 27.52M | 180.00K | 242.62M | 114.59M | |||
| Other Financing Activity | N/A | 0.00 | -1.16M | N/A | N/A | |||
| FINANCING CASH FLOW | 112.00K | 27.52M | -980.00K | 242.62M | 114.59M | |||
| Exchange Rate Effect | 6.80M | -12.44M | 300.00K | 11.74M | -1.01M | |||
| CHANGE IN CASH | -37.91M | -70.45M | -112.51M | 157.00M | 58.24M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -64.54M | -78.52M | -107.56M | -94.97M | -52.32M | |||
| Capital Expenditure | -4.54M | -7.01M | -4.27M | -2.51M | -3.02M | |||
| FREE CASH FLOW | -69.09M | -85.53M | -111.83M | -97.48M | -55.34M | |||
All data in USD